CRDF logo

Cardiff Oncology (CRDF) Depreciation And Amortization

Annual D&A

$398.00 K
+$162.00 K+68.64%

31 December 2023

1-Year Change

+68.64%
CRDF annual depreciation & amortization is up +68.64% year-on-year

3-Year Change

-14.59%
CRDF annual depreciation & amortization is down -14.59% over the past 3 years

All-time High

$1.25 M
CRDF annual depreciation & amortization is currently -68.10% below its historical high of $1.25 million

Sector Rank

25.24%
CRDF annual depreciation & amortization is higher than 25.24% of companies in Healthcare sector
Annual Total Expenses$45.90 M
CRDF annual total expenses is $45.90 million
Annual Operating Expenses$45.90 M
CRDF annual total operating expenses is $45.90 million
Annual Revenue$488.00 K
CRDF annual revenue is $488.00 thousand
Annual Net Income-$41.44 M
CRDF annual net profit is -$41.44 million

CRDF Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$101.00 K
-$4000.00-3.81%

30 September 2024

1-Year Change

-5.61%
CRDF quarterly depreciation & amortization is down -5.61% year-on-year

3-Year Change

-8.18%
CRDF quarterly depreciation & amortization is down -8.18% over the past 3 years

All-time High

$376.10 K
CRDF quarterly depreciation & amortization is currently -73.15% below its historical high of $376.10 thousand

Sector Rank

26.7%
CRDF quarterly depreciation & amortization is higher than 26.7% of companies in Healthcare sector
Quarterly Total Expenses$12.77 M
CRDF quarterly total expenses is $12.77 million
Quarterly Operating Expenses$12.77 M
CRDF quarterly total operating expenses is $12.77 million
Quarterly Revenue$165.00 K
CRDF quarterly revenue is $165.00 thousand
Quarterly Net Income-$11.86 M
CRDF quarterly net profit is -$11.86 million

CRDF Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$411.00 K
-$6000.00-1.44%

30 September 2024

1-Year Change

+7.87%
CRDF TTM depreciation & amortization is up +7.87% year-on-year

3-Year Change

-9.67%
CRDF TTM depreciation & amortization is down -9.67% over the past 3 years

All-time High

$1.33 M
CRDF TTM depreciation & amortization is currently -69.17% below its historical high of $1.33 million

Sector Rank

25.68%
CRDF TTM depreciation & amortization is higher than 25.68% of companies in Healthcare sector
Annual Total Expenses$45.90 M
CRDF annual total expenses is $45.90 million
Annual Operating Expenses$45.90 M
CRDF annual total operating expenses is $45.90 million
TTM Revenue$689.00 K
CRDF TTM revenue is $689.00 thousand
TTM Net Income-$42.98 M
CRDF TTM net profit is -$42.98 million

CRDF TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRDF Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+68.6%-5.6%+7.9%
3 y3 years-14.6%-8.2%-9.7%
5 y5 years-53.7%-18.5%-22.5%

CRDF Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-14.6%+68.6%-10.6%+225.8%-9.7%+74.2%
5 y5 years-53.7%+68.6%-18.5%+225.8%-22.5%+74.2%
alltimeall time-68.1%+4638.1%-73.2%+3784.6%-69.2%>+9999.0%

Cardiff Oncology Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$101.00 K(-3.8%)
$411.00 K(-1.4%)
June 2024
-
$105.00 K(+2.9%)
$417.00 K(+1.7%)
Mar 2024
-
$102.00 K(-1.0%)
$410.00 K(+3.0%)
Dec 2023
$398.00 K(+68.6%)
$103.00 K(-3.7%)
$398.00 K(+4.5%)
Sept 2023
-
$107.00 K(+9.2%)
$381.00 K(+7.3%)
June 2023
-
$98.00 K(+8.9%)
$355.00 K(+20.3%)
Mar 2023
-
$90.00 K(+4.7%)
$295.00 K(+25.0%)
Dec 2022
$236.00 K(-47.7%)
$86.00 K(+6.2%)
$236.00 K(-10.3%)
Sept 2022
-
$81.00 K(+113.2%)
$263.00 K(-9.9%)
June 2022
-
$38.00 K(+22.6%)
$292.00 K(-19.6%)
Mar 2022
-
$31.00 K(-72.6%)
$363.00 K(-19.5%)
Dec 2021
$451.00 K(-3.2%)
$113.00 K(+2.7%)
$451.00 K(-0.9%)
Sept 2021
-
$110.00 K(+0.9%)
$455.00 K(-1.1%)
June 2021
-
$109.00 K(-8.4%)
$460.00 K(-1.3%)
Mar 2021
-
$119.00 K(+1.7%)
$466.00 K(0.0%)
Dec 2020
$466.00 K(-5.7%)
$117.00 K(+1.7%)
$466.00 K(-0.9%)
Sept 2020
-
$115.00 K(0.0%)
$470.40 K(-1.9%)
June 2020
-
$115.00 K(-3.4%)
$479.30 K(-1.5%)
Mar 2020
-
$119.00 K(-2.0%)
$486.50 K(-1.6%)
Dec 2019
$494.20 K(-42.5%)
$121.40 K(-2.0%)
$494.30 K(-6.8%)
Sept 2019
-
$123.90 K(+1.4%)
$530.60 K(-15.1%)
June 2019
-
$122.20 K(-3.6%)
$625.00 K(-14.8%)
Mar 2019
-
$126.80 K(-19.6%)
$733.80 K(-14.6%)
Dec 2018
$859.50 K(-31.1%)
$157.70 K(-27.8%)
$859.50 K(-13.4%)
Sept 2018
-
$218.30 K(-5.5%)
$992.40 K(-8.5%)
June 2018
-
$231.00 K(-8.5%)
$1.09 M(-7.2%)
Mar 2018
-
$252.50 K(-13.1%)
$1.17 M(-6.3%)
Dec 2017
$1.25 M
$290.60 K(-6.6%)
$1.25 M(-6.4%)
DateAnnualQuarterlyTTM
Sept 2017
-
$311.00 K(-1.3%)
$1.33 M(+8.7%)
June 2017
-
$315.00 K(-4.8%)
$1.23 M(-1.4%)
Mar 2017
-
$331.00 K(-12.0%)
$1.24 M(+16.3%)
Dec 2016
$1.07 M(+182.4%)
$376.10 K(+84.5%)
$1.07 M(+30.2%)
Sept 2016
-
$203.80 K(-38.8%)
$821.60 K(+14.8%)
June 2016
-
$332.90 K(+112.3%)
$715.40 K(+53.2%)
Mar 2016
-
$156.80 K(+22.4%)
$467.00 K(+23.3%)
Dec 2015
$378.70 K(+61.3%)
$128.10 K(+31.3%)
$378.70 K(+19.9%)
Sept 2015
-
$97.60 K(+15.5%)
$315.80 K(+14.2%)
June 2015
-
$84.50 K(+23.4%)
$276.50 K(+10.7%)
Mar 2015
-
$68.50 K(+5.1%)
$249.80 K(+6.4%)
Dec 2014
$234.80 K(+79.9%)
$65.20 K(+11.8%)
$234.80 K(+9.4%)
Sept 2014
-
$58.30 K(+0.9%)
$214.60 K(+8.4%)
June 2014
-
$57.80 K(+8.0%)
$197.90 K(+19.0%)
Mar 2014
-
$53.50 K(+18.9%)
$166.30 K(+27.3%)
Dec 2013
$130.50 K(+212.2%)
$45.00 K(+8.2%)
$130.60 K(+29.2%)
Sept 2013
-
$41.60 K(+58.8%)
$101.10 K(+40.6%)
June 2013
-
$26.20 K(+47.2%)
$71.90 K(+34.4%)
Mar 2013
-
$17.80 K(+14.8%)
$53.50 K(+27.7%)
Dec 2012
$41.80 K(+305.8%)
$15.50 K(+25.0%)
$41.90 K(+44.5%)
Sept 2012
-
$12.40 K(+59.0%)
$29.00 K(+51.0%)
June 2012
-
$7800.00(+25.8%)
$19.20 K(+37.1%)
Mar 2012
-
$6200.00(+138.5%)
$14.00 K(+34.6%)
Dec 2011
$10.30 K(+22.6%)
$2600.00(0.0%)
$10.40 K(+33.3%)
Sept 2011
-
$2600.00(0.0%)
$7800.00(+50.0%)
June 2011
-
$2600.00(0.0%)
$5200.00(+100.0%)
Mar 2011
-
$2600.00
$2600.00
Dec 2010
$8400.00
-
-

FAQ

  • What is Cardiff Oncology annual depreciation & amortization?
  • What is the all time high annual D&A for Cardiff Oncology?
  • What is Cardiff Oncology annual D&A year-on-year change?
  • What is Cardiff Oncology quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Cardiff Oncology?
  • What is Cardiff Oncology quarterly D&A year-on-year change?
  • What is Cardiff Oncology TTM depreciation & amortization?
  • What is the all time high TTM D&A for Cardiff Oncology?
  • What is Cardiff Oncology TTM D&A year-on-year change?

What is Cardiff Oncology annual depreciation & amortization?

The current annual D&A of CRDF is $398.00 K

What is the all time high annual D&A for Cardiff Oncology?

Cardiff Oncology all-time high annual depreciation & amortization is $1.25 M

What is Cardiff Oncology annual D&A year-on-year change?

Over the past year, CRDF annual depreciation & amortization has changed by +$162.00 K (+68.64%)

What is Cardiff Oncology quarterly depreciation & amortization?

The current quarterly D&A of CRDF is $101.00 K

What is the all time high quarterly D&A for Cardiff Oncology?

Cardiff Oncology all-time high quarterly depreciation & amortization is $376.10 K

What is Cardiff Oncology quarterly D&A year-on-year change?

Over the past year, CRDF quarterly depreciation & amortization has changed by -$6000.00 (-5.61%)

What is Cardiff Oncology TTM depreciation & amortization?

The current TTM D&A of CRDF is $411.00 K

What is the all time high TTM D&A for Cardiff Oncology?

Cardiff Oncology all-time high TTM depreciation & amortization is $1.33 M

What is Cardiff Oncology TTM D&A year-on-year change?

Over the past year, CRDF TTM depreciation & amortization has changed by +$30.00 K (+7.87%)